Post-approval studies (Phase 4)Study completedNCT05357573
What this trial is testing
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With TIO
Who this might be right for
Tumor-Induced Osteomalacia (TIO)
Kyowa Kirin Co., Ltd. 9